Agfa HealthCare and Montpellier CHRU in France Announce Strategic Partnership for ORBIS

Agfa HealthCareAgfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, announces today that it has signed an agreement with Montpellier CHRU for the installation of its leading Hospital/Clinical Information System (HIS/CIS) ORBIS across its seven facilities.

Montpellier CHRU is one of France's leading care facilities with seven institutions providing a full spectrum of healthcare. As an academic hospital, it provides critical care, teaching and research services. It is the country's fifth largest University Hospital and has 3,000 beds. Montpellier CHRU employs 9000 staff members. CHRU is a key healthcare player in France, with an international reputation, it ranks fourth in the Le Point 2005-2009 overview of leading facilities in France and ranked 7th in the AERES (Agence d'évaluation de la recherche et de l'enseignement supérieur) 2009 rankings for its medical research capabilities.

Under the terms of this agreement, the Montpellier CHRU will become the showcase in France for Agfa HealthCare's patient information solutions and will be a key reference site. "This new agreement and the partnership are of strategic importance to Agfa HealthCare, not only on the national level but, thanks to the prominence of the CHRU, on an international level as well," says Philippe Blanco, Managing Director of Agfa HealthCare France.

Agfa HealthCare's ORBIS patient information system will enable information exchanges in real time between all specialists and nursing staff involved throughout the patient care process. The introduction of the solution is part of a larger project to further streamline and improve the facilities' operations.

The project foresees the use of some of the most powerful business intelligence tools to achieve this. This solution (ORBIS), customized for data traceability and collection (formalization and analysis of protocols), will also allow the Montpellier CHRU to develop medical research.

"We will increase the efficiency of the Montpellier CHRU through more rigorous management of our healthcare provision. Our partnership with Agfa HealthCare is therefore truly strategic," states Mr. Manville, Managing Director of the Montpellier CHRU.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures, and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare), and specific industrial applications (Agfa Materials). Agfa has its headquarters in Mortsel, Belgium. The company is active in 40 countries, and has agents in another 100 countries throughout the world. Agfa achieved a turnover of 3.032 billion Euros in 2008.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing, processing and printing images in hospitals and healthcare facilities. The company has over a century of experience in diagnostic imaging and has been a pioneer in the healthcare IT market since the early 1990's. Sales for Agfa HealthCare in 2008 were approx. 1.223 billion Euros.

About the Montpellier CHU
The Montpellier university hospital is comprised of several institutions situated in Montpellier: the Lapeyronie hospitals, Arnaud de Villeneuve, Saint Eloi, Gui de Chauliac, La Colombière, the Bellevue healthcare centre for the elderly and the Antonin Balmès clinical gerontology center.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...